<?xml version="1.0" encoding="UTF-8"?> 
<article><sponsor name="GSK"/><article_title name="Study AMB107816, Clinical Evaluation of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension (PAH)- An Open-Label Phase II/III Study to evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A"/><sponsor_identification_number name="AMB107816"/><trial_registry_identification_number/></article><article><sponsor name="GSK"/><article_title name="GSK1550188, A randomised, single-blind, placebo controlled, dose ascending, single dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamic of GSK1550188 in Japanese subjects with Systemic Lupus Erythematosus (SLE)"/><sponsor_identification_number name="BEL114243"/><trial_registry_identification_number name="NCT01381536"/><medical_condition name="Systemic Lupus Erythematosus"/><phase name="Phase 1"/><link_to_study_details_bi_clinical name="http://www.gsk-clinicalstudyregister.com/study/114243"/><link_to_study_details_other name="http://clinicaltrials.gov/show/NCT01381536"/><data_sets_documents name="error"><Analysis-ready_dataset/><Reporting_and_analysis_plan/><Clinical_study_report/><Raw_dataset/><Annotated_case_report_form/><Dataset_specifications/><Protocol_with_any_amendments/></data_sets_documents><date_added_to_site name="July 2015"/></article><article><sponsor name="GSK"/><article_title name="A Multicenter, Randomized, Double-Blind, Phase 3 Study of the Safety and Efficacy of Emulsion Formulation U0267, versus Vehicle in Subjects with Plaque-type Psoriasis"/><sponsor_identification_number name="STF114741"/><trial_registry_identification_number name="NCT00688519"/><medical_condition name="Psoriasis"/><phase name="Phase 3"/><link_to_study_details_bi_clinical name="http://www.gsk-clinicalstudyregister.com/study/114741"/><link_to_study_details_other name="http://clinicaltrials.gov/show/NCT00688519"/><data_sets_documents><Analysis-ready_dataset name="checked"/><Reporting_and_analysis_plan name="checked"/><Clinical_study_report name="checked"/><Raw_dataset name="checked"/><Annotated_case_report_form name="checked"/><Dataset_specifications name="checked"/><Protocol_with_any_amendments name="checked"/></data_sets_documents><date_added_to_site name="July 2015"/></article><article><sponsor name="GSK"/><article_title name="Study AMB107818, Clinical Evaluation of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension (PAH)- An open label Study of GSK1325760A to evaluate the Safety and Efficacy of GSK1325760A - a Long-term Extension Study -"/><sponsor_identification_number name="AMB107818"/><trial_registry_identification_number/></article><article><sponsor name="GSK"/><article_title/></article><article><sponsor name="GSK"/><article_title name="Two-week Study to Determine and Compare the Tolerance and Irritation Potential of Clindamycin and Benzoyl Peroxide to Dapsone Gel Topical Acne Medications"/><sponsor_identification_number name="STF114545"/><trial_registry_identification_number/></article><article><sponsor name="GSK"/><article_title name="Two-week Study to Determine and Compare the Tolerance and Irritation Potential of Duac&#174; Topical Gel (clindamycin 1% and benzoyl peroxide 5%) to ACANYA&#8482; Gel (clindamycin phosphate 1.2% and benzoyl peroxide 2.5%) Topical Acne Medications"/><sponsor_identification_number name="STF114546"/><trial_registry_identification_number name="NCT01015638"/><medical_condition name="Acne Vulgaris"/><phase name="Phase 4"/><link_to_study_details_bi_clinical name="http://www.gsk-clinicalstudyregister.com/study/114546"/><link_to_study_details_other name="http://clinicaltrials.gov/show/NCT01015638"/><data_sets_documents><Analysis-ready_dataset name="checked"/><Reporting_and_analysis_plan name="checked"/><Clinical_study_report name="checked"/><Raw_dataset name="checked"/><Annotated_case_report_form name="checked"/><Dataset_specifications name="checked"/><Protocol_with_any_amendments name="checked"/></data_sets_documents><date_added_to_site name="August 2014"/></article><article><sponsor name="GSK"/><article_title name="A single-blind, randomized, comparative split-face study evaluating the tolerability of clindamycin and benzoyl peroxide gel to benzoyl peroxide/adapalene gel in the treatment of acne vulgaris."/><sponsor_identification_number name="STF114547"/><trial_registry_identification_number name="NCT00964223"/><medical_condition name="Acne Vulgaris"/><phase name="Phase 4"/><link_to_study_details_bi_clinical name="http://www.gsk-clinicalstudyregister.com/study/114547"/><link_to_study_details_other name="http://clinicaltrials.gov/show/NCT00964223"/><data_sets_documents><Analysis-ready_dataset name="checked"/><Reporting_and_analysis_plan name="checked"/><Clinical_study_report name="checked"/><Raw_dataset name="checked"/><Annotated_case_report_form name="checked"/><Dataset_specifications name="checked"/><Protocol_with_any_amendments name="checked"/></data_sets_documents><date_added_to_site name="August 2014"/></article><article><sponsor name="GSK"/><article_title name="A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of Tazorac Cream when used in Combination with Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris"/><sponsor_identification_number name="STF114566"/><trial_registry_identification_number name="NCT01016977"/><medical_condition name="Acne Vulgaris"/><phase name="Phase 4"/><link_to_study_details_bi_clinical name="http://www.gsk-clinicalstudyregister.com/study/114566"/><link_to_study_details_other name="http://clinicaltrials.gov/show/NCT01016977"/><data_sets_documents><Analysis-ready_dataset name="checked"/><Reporting_and_analysis_plan name="checked"/><Clinical_study_report name="checked"/><Raw_dataset name="checked"/><Annotated_case_report_form name="checked"/><Dataset_specifications name="checked"/><Protocol_with_any_amendments name="checked"/></data_sets_documents><date_added_to_site name="August 2014"/></article>